Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
Dermatomyositis
•
Dermatology
•
Alopecia
•
Hair disorders
•
SLE
What specific historical questions do you prioritize when evaluating hair loss to identify features suggestive of autoimmune or connective tissue disorders?
Related Questions
Do you reduce the dose of hydroxychloroquine in patients with skin graying if they are not particularly bothered by this side effect?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
What are your vaccine recommendations while patients are on biologics?
In an elderly male with recurrent unilateral exudative pleural effusion, +ANA 1:1280, homogeneous and +anti-Smith antibody, but no other lupus features, how do you decide between escalating immunosuppression versus pursuing pleurodesis?
How do you taper corticotropin injections (Acthar) in patients with rheumatologic disease?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
How do you manage recalcitrant tumid lupus in a patient with partial response to antimalarials and off-label apremilast, in the setting of coexisting MDS with significant neutropenia?
How would you approach diagnosis of a patient with recurrent episodes of abdominal pain, severe myalgias, low grade fevers and urticaria?
How do you approach sequentially tapering combination therapy (i.e., IVIG, mycophenolate, rituximab) for dermatomyositis that is in remission?
Do you check IgA levels before starting IVIG for other autoimmune conditions?
